ABSTRACTS

483 – A 90-YEAR-OLD WOMAN WITH INVASIVE LOBULAR CARCINOMA SUCCESSFULLY TREATED WITH CHEMOTHERAPY: A CASE REPORT

4 – ABBREVIATED MRI PROTOCOL TO EVALUATE RESPONSE TO BREAST CANCER NEOADJUVANT CHEMOTHERAPY

536 – ANALYTICAL CROSS-SECTIONAL STUDY TO ASSESS THE IMPACT OF THE COVID-19 PANDEMIC ON THE STAGING OF BREAST CANCER PATIENTS  

468 – ANALYSIS OF WOMEN WITH BREAST CANCER WHO UNDERWENT IMMEDIATE OR LATE BREAST RECONSTRUCTION

509 – ASSOCIATION BETWEEN LEVONORGESTREL- RELEASING INTRAUTERINE SYSTEM AND BREAST CANCER

547 – EVALUATION OF PATHOLOGIC COMPLETE RESPONSE, DISEASE-FREE SURVIVAL, AND GLOBAL SURVIVAL OF PATIENTS WITH BREAST CANCER, TRIPLE-NEGATIVE SUBTYPE, WHO UNDERWENT PLATINUM-BASED NEOADJUVANT CHEMOTHERAPY AT HOSPITAL DE CÂNCER DE PERNAMBUCO IN 2018–2021

474 – AXILLARY ACCESSORY BREAST SARCOMA IN A YOUNG PATIENT

2 – AXILLARY SCHWANNOMA MIMETIZING LOCALLY ADVANCED BREAST CANCER: A CASE REPORT

537 – SYNCHRONOUS BILATERAL CARCINOMA IN SITU: A CASE REPORT

45 – BREAST ANGIOSSARCOMA IN A MALE PATIENT: A CASE REPORT

526 – BREAST CANCER BARRIERS IN A LOW AND MIDDLE INCOME COUNTRY: EVALUATION OF FACTORS ASSOCIATED WITH EARLY DIAGNOSIS AND BEGINNING OF TREATMENT

499 – BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA: A LITERATURE REVIEW

538 – BREAST LIPOSARCOMA

527 – BREAST ULTRASONOGRAPHY IN THE MEASUREMENT OF RESIDUAL TUMOR AFTER NEOADJUVANT CHEMOTHERAPY

528 – A CASE REPORT: BREAST MYIASIS — AN UNCOMMON DISEASE

8 – CASTLEMAN DISEASE IN A PATIENT WITH rAXILLARY LYMPH NODE ENLARGEMENT

555 – CLINICAL AND HISTOPATHOLOGICAL PROFILE OF BREAST CANCER AMONG YOUNG WOMEN IN A REFERENCE HOSPITAL IN PARAÍBA

81 – COMPLICATIONS FOLLOWING 1001 NIPPLESPARING MASTECTOMIES: A BRAZILIAN COHORT

490 – CONCERNING A FAMILY WITH BRCA2 MUTATION

1 – DERMATOFIBROSARCOMA OF THE BREAST: A CASE REPORT

534 – DERMATOMYOSITIS AS PARANEOPLASTIC SYNDROME OF A BREAST CANCER

35 – DERMATOMYOSITIS: A RARE PARANEOPLASTIC SYNDROME IN BREAST CANCER

517 – DERMOSCOPY OF THE PAPILLA TO THE IDENTIFICATION OF HUMAN PAPILLOMAVIRUS SIGNS IN TEN BREAST CANCER PATIENTS COMPARED TO TEN CONTROLS WITHOUT BREAST COMPLAINTS

512 – DESCRIPTIVE EPIDEMIOLOGICAL PROFILE OF PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER SUBMITTED TO PERTUZUMAB AND TRASTUZUMAB AT THE CANCER HOSPITAL OF PERNAMBUCO

69 – DIAGNOSIS OF BREAST CANCER ASSOCIATED WITH PREGNANCY: A REVIEW OF LITERATURE

532 – DIAGNOSIS OF BREAST CANCER IN BRAZIL: REFLECTION ON THE IMPACT OF THE COVID-19 PANDEMIC

7 – DUCTAL CARCINOMA IN SITU OF BREAST: CASES ANALYSIS IN AN ACADEMIC HOSPITAL IN THE FEDERAL DISTRICT

522 – EFFECT OF ACUPUNCTURE AND EXERCISE THERAPY IN REHABILITATION OF PHYSICAL DYSFUNCTIONS ON WOMEN BREAST CANCER SURVIVORS

523 – EFFECT OF ACUPUNCTURE AND EXERCISE THERAPY ON MUSCULAR STRENGTH, LYMPHEDEMA, AND QUALITY OF LIFE IN BREAST CANCER SURVIVORS

479 – EPIDEMIOLOGICAL CHARACTERISTICS AND INCIDENCE OF BREAST CANCER IN MALE PATIENTS IN A TERTIARY HEALTH INSTITUTION

524 – RETROSPECTIVE CROSS-SECTIONAL ANALYTICAL STUDY ON PREGNANCY-ASSOCIATED BREAST CANCER IN PATIENTS TREATED AT A CANCER CENTER

8 – EXERCISE AS AN ADJUVANT THERAPY FOR FATIGUE AND CARDIORESPIRATORY FITNESS IN BREAST CANCER PATIENTS: A REVIEW OF CURRENT EVIDENCE

486 – EXTENSIVE DERMATOFIBROSARCOMA PROTUBERANS IN THE CHEST AND BREAST: A CASE REPORT

519 – FIBROADENOMA AND PHYLOID TUMOR: CLINICAL DIFFERENCES AND IN IMAGING EXAMINATIONS

513 – FIBROADENOMA ARISING IN SUPERNUMERARY AXILARY BREAST TISSUE

546 – GIANT CELL TUMOR OF THE BREAST WITH PULMONARY METASTASIS: A CASE REPORT

489 – GIANT MALIGNANT PHYLLODES TUMOR: A RARE CASE REPORT

477 – GIANT PHYLLODES BREAST TUMOR AFTER INDUSTRIAL SILICONE INJECTIONS: A CASE REPORT

463 – GRANULOMATOUS MASTITIS CAUSED BY HISTOPLASMA CAPSULATUM

478 – HIGH LEVELS OF SATISFACTION WITH CARE AFTER BREAST CANCER SURGERY

488 – HISTOPATHOLOGICAL AND EPIDEMIOLOGICAL PROFILE OF PATIENTS WITH INVASIVE LOBULAR CARCINOMA OF THE BREAST TREATED AT A REFERENCE HOSPITAL

514 – HMGB1 EXPRESSION IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER: IS A GOOD MARKER FOR PROGNOSIS?

485 – IMPACT OF A SHORT TRAINING PROGRAM IN MAMMOGRAPHIC POSITIONING IN THE CLINICAL QUALITY OF THE EXAMINATION

460 – IMPACT OF DELAYED ADJUVANT RADIOTHERAPY ON BREAST CANCER

510 – IMPLEMENTING AN EXERCISE ONCOLOGY PROGRAM FOR BREAST CANCER PATIENTS IN BRAZIL: THE MAPLE TREE CANCER ALLIANCE EXPERIENCE

480 – INDICATIONS AND OUTCOMES OF BREAST CANCER PATIENTS UNDERGOING NSM: YOUNG VERSUS ELDERLY WOMEN

461 – INVASIVE CARCINOMA IN A FIBROADENOMA

482 – INVASIVE LOBULAR BREAST CANCER METASTATIC TO THE ORBIT: A CASE REPORT

5 – CO2 LASER THERAPY IMPROVING THE SEX LIFE OF WOMEN AFTER BREAST CANCER TREATMENT: 92 CASES

465 – LESIONS OF UNCERTAIN MALIGNANT POTENTIAL (B3): A REVIEW OF LITERATURE

467 – LI-FRAUMENI SYNDROME: A CASE REPORT

471 – LIVER TRANSPLANTATION IN A FEMALE PATIENT WITH PREVIOUS HISTORY OF BREAST CANCER

472 – MALE BREAST CANCER AFTER LIVER TRANSPLANTATION: A CASE REPORT

462 – MALE BREAST CANCER CASE REPORT OF AN INVASIVE CARCINOMA OF A NONSPECIAL AND INVASIVE DUCTAL TYPE 2 IN A MALE PATIENT

502 – METAPLASTIC CARCINOMA OF THE BREAST WITH CHONDROID-TYPE MESENCHYMAL DIFFERENTIATION: A CASE REPORT

541 – MODIFIED “NO-VERTICAL-SCAR” REDUCTION MAMMOPLASTY: A SAFE ONCOPLASTIC OPTION FOR PATIENTS WITH EXTREMELY LARGE AND PTOTIC BREASTS

501 – MOLECULAR SUBTYPES OF BREAST CANCER IN WOMEN SEEN AT A PUBLIC HOSPITAL IN THE FEDERAL DISTRICT

539 – NEGATIVE IMPACT OF SERUM VITAMIN D DEFICIENCY ON BREAST CANCER SURVIVAL

533 – NIPPLE MINIMUM PAGET DISEASE: A CASE REPORT

531 – NODULAR FASCIITIS OF THE BREAST: A CASE REPORT

476 – ONCOLOGICAL OUTCOME IN PATIENTS SUBMITTED TO NIPPLE-AREOLA COMPLEX SPARING MASTECTOMY AFTER NEODADJUVANT CHEMOTHERAPY

549 – ONCOPLASTICS AS A SURGICAL APPROACH FOR THE MAINTENANCE OF SELF-ESTEEM IN WOMEN WITH BREAST CANCER

491 – EPIDEMIOLOGICAL PROFILE OF WOMEN WITH BREAST CANCER SUBMITTED TO BREAST RECONSTRUCTION IN A TERTIARY HOSPITAL IN PERNAMBUCO

459 – POSITIVE PREDICTIVE VALUES OF THE BREAST IMAGING REPORTING AND DATA SYSTEM (BI-RADS®) CATEGORIES 4, 5, AND 0 IN MAMMOGRAPHY AND ULTRASOUND EXAMINATIONS: ANALYSIS BASED ON LOCAL CLINICAL PRACTICE

475 – POST-NEOADJUVANT CHEMOTHERAPY RECURRENCE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER: INFLUENCE OF DIFFERENT AXILLARY APPROACHES

466 – PREDICTIVE FACTORS OF PATHOLOGIC COMPLETE RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER

552 – PROBABILITY OF LOCAL RECURRENCE ESTIMATED BY A MODIFIED MSKCC DCIS NOMOGRAM IN PATIENTS WITH DUCTAL CARCINOMA IN SITU TREATED WITH BREASTCONSERVING SURGERY: A NOVEL TOOL FOR  RADIOTHERAPY DECISION-MAKING

554 – QUALITY OF LIFE OF YOUNG WOMEN WITH BREAST CANCER IN A REFERENCE HOSPITAL IN PARAÍBA

473 – RECURRENCE POST-NEOADJUVANT THERAPY IN PATIENTS WITH NODE-POSITIVE BREAST CANCER

495 – RECURRENT PHYLLODES TUMOR MALIGNANCY: A CASE REPORT

504 – SPONTANEOUS REGRESSION OF MALIGNANT BREAST NEOPLASM IN A PATIENT WITH HIGH LEVELS OF IMMUNOGLOBULIN E

484 – RELEVANT PREDICTORS OF MALIGNANCY BEYOND THE ACR BI-RADS® ATLAS FOR ULTRASOUND

507 – ROSAI-DORFMAN DISEASE OF THE BREAST: A CASE REPORT

553 – SECOND BREAST CANCER IN A WOMAN WITH GENETIC SYNDROME

550 – SECRETORY CARCINOMA BREAST IN A YOUNG MAN

515 – SURGICAL EXERCISE OF INDUSTRIAL SILICONE IN A TRANSVESTI AFTER INFECTION: A CASE REPORT

464 – THE IMPORTANCE OF MANAGING B3 LESIONS: A CASE REPORT

516 – THE IMPORTANCE OF PROPER TREATMENT  OF LACTATIONAL MASTITIS

497 – TUBERCULOUS LYMPHADENITIS: A CASE REPORT

498 – TUBERCULOUS LYMPHADENITIS: A LITERATURE REVIEW

529 – TUMORAL EMBOLIZATION IN THE THERAPY OF LARGE BREAST TUMORS

525 – USE OF NEOADJUVANT CHEMOTHERAPY AND DISSECTION OF THE POSITIVE SENTINEL LYMPH NODES IN THE TREATMENT OF BREAST CANCER ONLY ON STAGES T1 TO T2